NO20051419L - Hasylerte polypeptider, spesielt hasylerte erytropoietin - Google Patents

Hasylerte polypeptider, spesielt hasylerte erytropoietin

Info

Publication number: NO20051419L
Authority: NO; Norway
Prior art keywords: hasylated; erythropoietin; polypeptides; polypeptide; conjugates
Prior art date: 2002-09-11

Application number

NO20051419A

Other languages

English (en)

Norwegian (no)

Inventor

Wolfram Eichner

Norbert Zander

Harald S Conradt

Eckart Grabenhorst

Manfred Nimtz

Ronald Frank

Original Assignee

Fresenius Kabi De Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-11

Filing date

2005-03-17

Publication date

2005-05-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31995520&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051419(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-09-11 Priority claimed from EP02020425A external-priority patent/EP1400533A1/fr

2005-03-17 Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh

2005-05-30 Publication of NO20051419L publication Critical patent/NO20051419L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/10—Alkyl or cycloalkyl ethers
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/12—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/003—Crosslinking of starch
- C08B31/006—Crosslinking of derivatives of starch
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/18—Oxidised starch
- C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Materials Engineering (AREA)
Genetics & Genomics (AREA)
Polymers & Plastics (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20051419A 2002-09-11 2005-03-17 Hasylerte polypeptider, spesielt hasylerte erytropoietin NO20051419L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US40978102P	2002-09-11	2002-09-11
EP02020425A EP1400533A1 (fr)	2002-09-11	2002-09-11	Polypeptides hasylés, érythropoiétine hasylée en particulier
PCT/EP2003/008858 WO2004024761A1 (fr)	2002-09-11	2003-08-08	Polypeptides-has, notamment, erythropoietine-has ayant subi une acylation

Publications (1)

Publication Number	Publication Date
NO20051419L true NO20051419L (no)	2005-05-30

Family

ID=31995520

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20051419A NO20051419L (no)	2002-09-11	2005-03-17	Hasylerte polypeptider, spesielt hasylerte erytropoietin
NO20051427A NO20051427L (no)	2002-09-11	2005-03-17	Fremgangsmate for produksjon av hydroksyalkyl stivelsesderivater

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20051427A NO20051427L (no)	2002-09-11	2005-03-17	Fremgangsmate for produksjon av hydroksyalkyl stivelsesderivater

Country Status (24)

Country	Link
US (5)	US8618266B2 (fr)
EP (8)	EP2017287A3 (fr)
JP (4)	JP2006516534A (fr)
KR (3)	KR101174510B1 (fr)
CN (2)	CN1681844A (fr)
AR (3)	AR041097A1 (fr)
AT (3)	ATE406387T1 (fr)
AU (6)	AU2003260393B2 (fr)
BR (3)	BR0314227A (fr)
CA (2)	CA2495242A1 (fr)
CY (1)	CY1109813T1 (fr)
DE (7)	DE60330098D1 (fr)
DK (3)	DK1398322T3 (fr)
ES (4)	ES2213505T3 (fr)
IL (5)	IL166506A0 (fr)
MX (4)	MXPA05002594A (fr)
NO (2)	NO20051419L (fr)
PL (3)	PL217085B1 (fr)
PT (3)	PT1398327E (fr)
RU (3)	RU2329274C2 (fr)
SI (2)	SI1398327T1 (fr)
TW (1)	TW200418875A (fr)
WO (3)	WO2004024761A1 (fr)
ZA (1)	ZA200600651B (fr)

Families Citing this family (159)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10112825A1 (de) *	2001-03-16	2002-10-02	Fresenius Kabi De Gmbh	HESylierung von Wirkstoffen in wässriger Lösung
DE10209821A1 (de)	2002-03-06	2003-09-25	Biotechnologie Ges Mittelhesse	Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de)	2002-03-06	2003-09-25	Biotechnologie Ges Mittelhesse	Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE10242076A1 (de) *	2002-09-11	2004-03-25	Fresenius Kabi Deutschland Gmbh	HAS-Allergen-Konjugate
DE02020425T1 (de) *	2002-09-11	2004-07-15	Fresenius Kabi Deutschland Gmbh	Hasylierte Polypeptide, besonders hasyliertes Erythropoietin
RU2329274C2 (ru)	2002-09-11	2008-07-20	Фрезениус Каби Дойчланд Гмбх	Способ получения производных гидроксиалкилкрахмала
US7538092B2 (en)	2002-10-08	2009-05-26	Fresenius Kabi Deutschland Gmbh	Pharmaceutically active oligosaccharide conjugates
DE10256558A1 (de) *	2002-12-04	2004-09-16	Supramol Parenteral Colloids Gmbh	Ester von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe
EP1653991A2 (fr) *	2003-08-08	2006-05-10	Fresenius Kabi Deutschland GmbH	Conjugues de polymere et de proteine lies au moyen d'un groupe de liaison oxime
WO2005014655A2 (fr) *	2003-08-08	2005-02-17	Fresenius Kabi Deutschland Gmbh	Conjugues d'amidon d'hydroxyalkyle et de proteine
MXPA06001358A (es) *	2003-08-08	2006-05-15	Fresenius Kabi Gmbh	Conjugados de hidroxialquil almidon y g-csf.
BRPI0413450A (pt) *	2003-08-08	2006-10-17	Fresenius Kabi De Gmbh	conjugados de hidroxialquil amido e g-csf
US8754031B2 (en)	2004-03-08	2014-06-17	Oncolix, Inc.	Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
TWI417303B (zh) *	2004-03-11	2013-12-01	Fresenius Kabi De Gmbh	經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物
CN1929865B (zh) *	2004-03-11	2011-11-16	费森尤斯卡比德国有限公司	羟烷基淀粉和蛋白质的接合物
EP1758608A2 (fr) *	2004-03-11	2007-03-07	Fresenius Kabi Deutschland GmbH	Conjugues d'hydroxy-ethyl-amidon et d'erythropoietine
US7589063B2 (en)	2004-12-14	2009-09-15	Aplagen Gmbh	Molecules which promote hematopoiesis
WO2006094826A2 (fr) *	2005-03-11	2006-09-14	Fresenius Kabi Deutschland Gmbh	Procede permettant de coupler des glycoconjugues actives sur le plan enzymatique a un compose de modification
EP1861124A2 (fr) *	2005-03-11	2007-12-05	Fresenius Kabi Deutschland GmbH	Production de glycoproteines bioactives a partir d'un materiau de depart inactif
EP1762250A1 (fr) *	2005-09-12	2007-03-14	Fresenius Kabi Deutschland GmbH	Conjugués d' amidon hydroxyalkyle et une substance active obtenue par ligation chimique via thiazolidine
EP3669894A3 (fr)	2006-06-30	2020-08-26	Syntab Therapeutics GmbH	Nouveaux composés multifonctionnels à usage pharmaceutique
WO2008012525A1 (fr) *	2006-07-25	2008-01-31	Lipoxen Technologies Limited	Dérivatisation du facteur de stimulation des colonies de granulocytes
JP2010510794A (ja)	2006-11-28	2010-04-08	ハナルファーマシューティカルカンパニーリミテッド	修飾型エリスロポエチンポリペプチド及びこの治療用用途
ES2521490T3 (es) *	2006-12-15	2014-11-12	Baxter International Inc.	Conjugado de factor VIIa - ácido (poli)siálico con una vida media in vivo prolongada.
ES2417146T3 (es)	2007-01-18	2013-08-06	Genzyme Corporation	Oligosacáridos que comprenden un grupo aminoxi y conjugados de los mismos
US8383114B2 (en)	2007-09-27	2013-02-26	Amgen Inc.	Pharmaceutical formulations
EP3381445B1 (fr)	2007-11-15	2023-10-25	Amgen Inc.	Formulation aqueuse d'anticorps stabilisée par des antioxydants pour administration parentérale
EP2070950A1 (fr) *	2007-12-14	2009-06-17	Fresenius Kabi Deutschland GmbH	Dérivés hydroxyalkylés de l'amidon et leur procédé de préparation
EP2070951A1 (fr) *	2007-12-14	2009-06-17	Fresenius Kabi Deutschland GmbH	Procédé de production d'un dérivé hydroxyalkyle de l'amidon avec deux liens
CN104888264B (zh)	2008-01-14	2018-01-09	北京环球利康科技有限公司	生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
EP2803675A3 (fr)	2008-01-25	2014-12-24	Amgen, Inc	Anticorps anti-ferroportine et procédés d'utilisation
CA2722425A1 (fr) *	2008-04-28	2009-11-05	Surmodics, Inc.	Matrices a base de poly-.alpha.(1-4)glucopyranose reticulees avec un hydrazide
JP2011519279A (ja)	2008-05-01	2011-07-07	アムジエン・インコーポレーテツド	抗ヘプシジン抗体及び使用の方法
EP2166085A1 (fr)	2008-07-16	2010-03-24	Suomen Punainen Risti Veripalvelu	Cellules modifiées bivalentes
NZ600382A (en)	2008-07-23	2013-11-29	Ambrx Inc	Modified bovine G-CSF polypeptides and their uses
WO2010033240A2 (fr) *	2008-09-19	2010-03-25	Nektar Therapeutics	Polymères à base de glucide pour administration de médicaments et leurs conjugués
WO2010056981A2 (fr)	2008-11-13	2010-05-20	Massachusetts General Hospital	Procédés et compositions pour la régulation de l'homéostasie du fer par modulation de la protéine bmp-6
CA2745592C (fr)	2008-12-06	2018-03-06	B. Braun Melsungen Ag	Composes medicaments-colloides mediateurs de transport
US8754035B2 (en)	2009-02-26	2014-06-17	Oncolix, Inc.	Compositions and methods for visualizing and eliminating cancer stem cells
US8648046B2 (en)	2009-02-26	2014-02-11	Oncolix, Inc.	Compositions and methods for visualizing and eliminating cancer stem cells
US9018372B2 (en)	2009-03-31	2015-04-28	B. Braun Melsungen Ag	Bonding products of aminated polysaccharides
US8642737B2 (en)	2010-07-26	2014-02-04	Baxter International Inc.	Nucleophilic catalysts for oxime linkage
US8809501B2 (en)	2009-07-27	2014-08-19	Baxter International Inc.	Nucleophilic catalysts for oxime linkage
JP5908401B2 (ja)	2009-07-27	2016-04-26	バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒＩｎｔｅｒｎａｔｉｏｎａｌＩｎｃｏｒｐ０Ｒａｔｅｄ	血液凝固タンパク質複合体
RU2744370C2 (ru) *	2009-07-27	2021-03-05	Баксалта Инкорпорейтед	Конъюгаты белков свертывания крови
NZ597600A (en) *	2009-07-27	2014-05-30	Lipoxen Technologies Ltd	Glycopolysialylation of non-blood coagulation proteins
CA2778105C (fr)	2009-10-23	2019-04-02	Amgen Inc.	Adaptateur de fiole et systeme
PE20121707A1 (es)	2009-12-21	2012-12-17	Ambrx Inc	Polipeptidos de somatotropina bovina modificados y sus usos
PE20121799A1 (es)	2009-12-21	2013-01-02	Ambrx Inc	Polipeptidos de somatotropina porcina modificados y sus usos
WO2011098095A1 (fr)	2010-02-09	2011-08-18	Aplagen Gmbh	Peptides se liant au récepteur de tpo
KR20180037303A (ko)	2010-06-07	2018-04-11	암젠 인크	약물 전달 장치
WO2012004007A1 (fr) *	2010-07-09	2012-01-12	Fresenius Kabi Deutschland Gmbh	Conjugués comprenant un amidon hydroxyalkylé et un agent cytotoxique et leur procédé de préparation
EP2590677A1 (fr) *	2010-07-09	2013-05-15	Fresenius Kabi Deutschland GmbH	Conjugués comprenant de l'hydroxyalkylamidon et un agent cytotoxique et leur procédé de synthèse
WO2012004009A1 (fr) *	2010-07-09	2012-01-12	Fresenius Kabi Deutschland Gmbh	Conjugués comprenant de l'hydroxyalkylamidon et un agent cytotoxique et leur procédé de synthèse
WO2012004004A1 (fr)	2010-07-09	2012-01-12	Fresenius Kabi Deutschland Gmbh	Dérivés d'hydroxyalkyl-amidon délivrant de l'oxyde nitrique
KR102269494B1 (ko)	2010-07-30	2021-06-25	박스알타 인코퍼레이티드	옥심 결합용 친핵성 촉매
TWI480288B (zh)	2010-09-23	2015-04-11	Lilly Co Eli	牛顆粒細胞群落刺激因子及其變體之調配物
NZ612320A (en)	2010-12-22	2015-06-26	Baxter Healthcare Sa	Materials and methods for conjugating a water soluble fatty acid derivative to a protein
AU2012236573B2 (en)	2011-03-31	2016-06-02	Amgen Inc.	Vial adapter and system
US10092706B2 (en)	2011-04-20	2018-10-09	Amgen Inc.	Autoinjector apparatus
EP2714093A1 (fr)	2011-05-27	2014-04-09	Baxter International Inc.	Protéines thérapeutiques à plus longue demi-vie et leurs procédés de préparation
WO2012170396A1 (fr) *	2011-06-07	2012-12-13	Philadelphia Health & Education Corporation	Bandelette de contrôle de la spla2
EP2741780A1 (fr)	2011-08-10	2014-06-18	Ludwig-Maximilians-Universität München	Procédé d'administration intracellulaire contrôlée d'acides nucléiques
LT3045187T (lt)	2011-10-14	2019-07-10	Amgen Inc.	Injekcijų įrenginys ir surinkimo būdas
WO2013113503A1 (fr)	2012-01-31	2013-08-08	Fresenius Kabi Deutschland Gmbh	Conjugués d'amidon hydroxyalkylé et d'un oligonucléotide
AU2013204754C1 (en)	2012-05-16	2018-10-11	Takeda Pharmaceutical Company Limited	Nucleophilic Catalysts for Oxime Linkage
EP3081249B1 (fr)	2012-11-21	2020-12-30	Amgen Inc.	Dispositif d'administration de médicaments
WO2014084110A1 (fr) *	2012-11-30	2014-06-05	株式会社糖鎖工学研究所	Lieur à chaîne glucidique liée, composé contenant un lieur à chaîne glucidique liée et substance physiologiquement active ou son sel, et son procédé de production
EP2968775B1 (fr)	2013-03-15	2019-12-18	Amgen Inc.	Boîte à médicament, autoinjecteur et système d'autoinjecteur
MX359794B (es)	2013-03-15	2018-10-10	Intrinsic Lifesciences Llc	Anticuerpos anti-hepcidina y usos de los mismos.
AU2014228177B2 (en)	2013-03-15	2018-04-26	Amgen Inc.	Body contour adaptable autoinjector device
WO2014144096A1 (fr)	2013-03-15	2014-09-18	Amgen Inc.	Cartouche à médicament, auto-injecteur et système d'auto-injection
US20160311933A1 (en) *	2013-03-20	2016-10-27	Fresenius Kabi Deutschland Gmbh	Process for the preparation of thiol functionalized hydroxyalkyl starch derivatives
AU2014234270A1 (en) *	2013-03-20	2015-10-08	Fresenius Kabi Deutschland Gmbh	Hydroxyalkyl starch derivatives as reactants for coupling to thiol groups
EP2976366A1 (fr) *	2013-03-20	2016-01-27	Fresenius Kabi Deutschland GmbH	Dérivés d'hydroxyalkylamidon utilisés comme réactifs pour couplage à des groupes thiol
CA2897825C (fr)	2013-03-22	2022-05-24	Scott R. Gibson	Injecteur et procede d'assemblage
JP6520712B2 (ja)	2013-09-24	2019-05-29	味の素株式会社	糖アミノ酸およびその用途
AU2014340171B2 (en)	2013-10-24	2019-05-30	Amgen Inc.	Injector and method of assembly
CA2926110C (fr)	2013-10-24	2023-05-23	Amgen Inc.	Systeme de distribution de medicaments equipe d'un dispositif de commande sensible a la temperature
WO2015119906A1 (fr)	2014-02-05	2015-08-13	Amgen Inc.	Système d'administration de médicament doté d'un générateur de champ électromagnétique
WO2015120427A2 (fr) *	2014-02-10	2015-08-13	Honeywell International Inc.	Conception de réacteur de fluoration en phase liquide
WO2015132724A1 (fr)	2014-03-05	2015-09-11	Pfizer Inc.	Mutéines améliorées du facteur viii de coagulation
CA3193070A1 (fr)	2014-05-07	2015-11-12	Amgen Inc.	Auto-injecteur comprenant des elements de reduction de choc
KR20170016335A (ko)	2014-06-03	2017-02-13	암겐 인코포레이티드	약물 전달 디바이스의 사용자를 보조하기 위한 디바이스들 및 방법들
CN104072608A (zh) *	2014-06-23	2014-10-01	山东齐都药业有限公司	含羧基羟乙基淀粉衍生物修饰的牛血清白蛋白偶联物及其制备方法
EP3197915A4 (fr)	2014-09-22	2018-12-19	Intrinsic Lifesciences LLC	Anticorps anti-hepcidine humanisés et utilisations de ceux-ci
MX392725B (es)	2014-10-14	2025-03-24	Amgen Inc	Dispositivo de inyeccion de farmaco con indicadores visuales y audibles.
ES2898469T3 (es)	2014-12-19	2022-03-07	Amgen Inc	Dispositivo de administración de medicamentos con sensor de proximidad
EP3233159B1 (fr)	2014-12-19	2020-03-04	Amgen Inc.	Dispositif d'administration de medicaments avec bouton bouge ou panneau d'interface utilisateur
AU2016220141B2 (en)	2015-02-17	2018-07-12	Amgen Inc.	Drug delivery device with vacuum assisted securement and/or feedback
EP3261690B1 (fr)	2015-02-27	2021-12-15	Amgen Inc.	Dispositif d'administration de médicament ayant un mécanisme de protection d'aiguille présentant un seuil réglable de résistance au mouvement de l'élément de protection d'aiguille
WO2017039786A1 (fr)	2015-09-02	2017-03-09	Amgen Inc.	Adaptateur d'ensemble de seringue pour une seringue
ES2755717T3 (es)	2015-12-09	2020-04-23	Amgen Inc	Autoinyector con tapa de señalización
US11154661B2 (en)	2016-01-06	2021-10-26	Amgen Inc.	Auto-injector with signaling electronics
DK3429663T3 (da)	2016-03-15	2020-09-28	Amgen Inc	Reduktion af sandsynligheden for glasbrud i anordninger til indgivelse af lægemidler
WO2017189089A1 (fr)	2016-04-29	2017-11-02	Amgen Inc.	Dispositif d'administration de médicament avec étiquette de messagerie
US11389588B2 (en)	2016-05-02	2022-07-19	Amgen Inc.	Syringe adapter and guide for filling an on-body injector
WO2017197222A1 (fr)	2016-05-13	2017-11-16	Amgen Inc.	Ensemble manchon de flacon
EP3458988B1 (fr)	2016-05-16	2023-10-18	Amgen Inc.	Chiffrement de données dans des dispositifs médicaux à capacité de calcul limitée
KR20190012189A (ko)	2016-05-20	2019-02-08	옥타파마 아게	약동학이 개선된 글리코실화 vwf 융합 단백질
GB201609083D0 (en)	2016-05-24	2016-07-06	Syntab Therapeutics Gmbh	Synthetic compound
EP3465124A1 (fr)	2016-06-03	2019-04-10	Amgen Inc.	Appareils et procédés d'essai au choc destinés aux dispositifs d'administration de médicaments
US11285266B2 (en)	2016-07-01	2022-03-29	Amgen Inc.	Drug delivery device having minimized risk of component fracture upon impact events
WO2018034784A1 (fr)	2016-08-17	2018-02-22	Amgen Inc.	Dispositif d'administration de médicament avec détection de positionnement.
WO2018081234A1 (fr)	2016-10-25	2018-05-03	Amgen Inc.	Injecteur porté sur le corps
MX2019008432A (es)	2017-01-17	2019-11-18	Amgen Inc	Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje.
MX2019009755A (es)	2017-02-17	2019-10-07	Amgen Inc	Mecanismo de insercion para dispositivo de suministro de farmacos.
US11752258B2 (en)	2017-02-17	2023-09-12	Amgen Inc.	Drug delivery device with sterile fluid flowpath and related method of assembly
AU2018231107B2 (en)	2017-03-06	2023-04-20	Amgen Inc.	Drug delivery device with activation prevention feature
EP3592402A1 (fr)	2017-03-07	2020-01-15	Amgen Inc.	Insertion d'aiguille par surpression
EP3592404A1 (fr)	2017-03-09	2020-01-15	Amgen Inc.	Mécanisme d'insertion pour dispositif d'administration de médicament
JP2020511499A (ja)	2017-03-20	2020-04-16	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	赤血球生成刺激タンパク質のインビトロでの糖鎖改変のための方法
EP4241807B1 (fr)	2017-03-28	2025-02-19	Amgen Inc.	Tige de piston ainsi que système d'assemblage de seringue
AU2018280054B2 (en)	2017-06-08	2023-07-13	Amgen Inc.	Syringe assembly for a drug delivery device and method of assembly
AU2018282077B2 (en)	2017-06-08	2023-11-23	Amgen Inc.	Torque driven drug delivery device
MA49447A (fr)	2017-06-22	2020-04-29	Amgen Inc	Réduction des impacts/chocs d'activation d'un dispositif
WO2018237225A1 (fr)	2017-06-23	2018-12-27	Amgen Inc.	Dispositif électronique d'administration de médicament comprenant un bouchon activé par un ensemble commutateur
MA49562A (fr)	2017-07-14	2020-05-20	Amgen Inc	Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion
EP3655063A1 (fr)	2017-07-21	2020-05-27	Amgen Inc.	Élément d'étanchéité perméable aux gaz pour récipient à médicament et procédés d'assemblage
US11484648B2 (en)	2017-07-25	2022-11-01	Amgen Inc.	Drug delivery device with container access system and related method of assembly
EP3658203B2 (fr)	2017-07-25	2025-10-01	Amgen Inc.	Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé
MA49838A (fr)	2017-08-09	2020-06-17	Amgen Inc	Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
MA49897A (fr)	2017-08-18	2020-06-24	Amgen Inc	Injecteur sur-corps avec patch adhésif stérile
US11103636B2 (en)	2017-08-22	2021-08-31	Amgen Inc.	Needle insertion mechanism for drug delivery device
MA50611A (fr)	2017-10-04	2020-08-12	Amgen Inc	Adaptateur d'écoulement destiné à un dispositif d'administration de médicament
IL272636B2 (en)	2017-10-06	2024-10-01	Amgen Inc	Drug delivery device with interlock assembly and related method of assembly
IL273323B2 (en)	2017-10-09	2024-10-01	Amgen Inc	Drug delivery device with drive assembly and related assembly method
EP3703778A1 (fr)	2017-11-03	2020-09-09	Amgen Inc.	Système et approches pour stériliser un dispositif d'administration de médicament
US20200261648A1 (en)	2017-11-06	2020-08-20	Amgen Inc.	Drug delivery device with placement and flow sensing
EP3707075A1 (fr)	2017-11-06	2020-09-16	Amgen Inc.	Ensembles de remplissage-finition et procédés associés
CN111225696B (zh)	2017-11-10	2023-07-18	安进公司	用于药物递送装置的柱塞
WO2019099324A1 (fr)	2017-11-16	2019-05-23	Amgen Inc.	Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament
MX2020005066A (es)	2017-11-16	2020-08-20	Amgen Inc	Autoinyector con deteccion de detencion y punto final.
CN108219019B (zh) *	2018-02-08	2020-03-20	华中科技大学	一种巯基化羟乙基淀粉及其修饰的纳米材料和制备方法
CN108503718B (zh) *	2018-02-08	2020-03-20	华中科技大学	一种羟烷基淀粉偶联物及其制备方法和应用
CN108403641B (zh) *	2018-02-08	2020-03-20	华中科技大学	一种载药纳米材料及其制备方法
EA202090767A1 (ru) *	2018-05-04	2020-08-03	Борис Славинович ФАРБЕР	Фармацевтическая композиция на основе полимиксина для лечения инфекционных заболеваний
US10835685B2 (en)	2018-05-30	2020-11-17	Amgen Inc.	Thermal spring release mechanism for a drug delivery device
US11083840B2 (en)	2018-06-01	2021-08-10	Amgen Inc.	Modular fluid path assemblies for drug delivery devices
EP3826701A1 (fr)	2018-07-24	2021-06-02	Amgen Inc.	Dispositifs d'administration pour l'administration de médicaments
WO2020023451A1 (fr)	2018-07-24	2020-01-30	Amgen Inc.	Dispositifs d'administration pour l'administration de médicaments
WO2020023336A1 (fr)	2018-07-24	2020-01-30	Amgen Inc.	Dispositifs hybrides d'administration de médicament dotés d'une partie de préhension
WO2020023220A1 (fr)	2018-07-24	2020-01-30	Amgen Inc.	Dispositifs d'administration de médicament hybrides dotés d'une partie de fixation collante à placer sur la peau et procédé de préparation associé
CA3103105A1 (fr)	2018-07-31	2020-02-06	Amgen Inc.	Ensemble de trajet de fluide pour dispositif d'administration de medicament
MA53724A (fr)	2018-09-24	2021-12-29	Amgen Inc	Systèmes et procédés de dosage interventionnel
CA3110371A1 (fr)	2018-09-28	2020-04-02	Amgen Inc.	Ensemble d'activation d'echappement de fil de muscle pour un dispositif d'administration de medicament
AU2019352616B2 (en)	2018-10-02	2024-10-10	Amgen Inc.	Injection systems for drug delivery with internal force transmission
TW202529830A (zh)	2018-10-05	2025-08-01	美商安進公司	具有劑量指示器之藥物遞送裝置
EA202191037A1 (ru)	2018-10-15	2021-08-05	Эмджен Инк.	Устройство доставки лекарственного средства, имеющее демпферный механизм
SG11202101824VA (en)	2018-10-15	2021-03-30	Amgen Inc	Platform assembly process for drug delivery device
WO2020091956A1 (fr)	2018-11-01	2020-05-07	Amgen Inc.	Dispositifs d'administration de médicament avec rétraction partielle de l'organe d'administration de médicament
TWI831847B (zh)	2018-11-01	2024-02-11	美商安進公司	部分針頭縮回之藥物遞送裝置及其操作方法
EP3873563A1 (fr)	2018-11-01	2021-09-08	Amgen Inc.	Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
CN111157736A (zh) *	2018-11-08	2020-05-15	中国科学院大连化学物理研究所	一种基于化学酶促的人血清o糖基化鉴定方法
US20220160972A1 (en)	2019-04-24	2022-05-26	Amgen Inc.	Syringe sterilization verification assemblies and methods
WO2021041067A2 (fr)	2019-08-23	2021-03-04	Amgen Inc.	Dispositif d'administration de médicament doté de composants configurables de mise en prise de protection d'aiguille et méthodes associées
EP4341161A1 (fr)	2021-05-21	2024-03-27	Amgen Inc.	Procédé d?optimisation d?une recette de remplissage pour un récipient de médicament
EP4612312A1 (fr)	2022-11-02	2025-09-10	F. Hoffmann-La Roche AG	Procédé de production de compositions de glycoprotéines
AR131133A1 (es)	2023-05-24	2025-02-19	Ambrx Inc	INTERFERÓN l BOVINO PEGILADO Y MÉTODOS DE USO DEL MISMO

Family Cites Families (159)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE279486C (fr)
US3191291A (en)	1959-01-21	1965-06-29	Continental Can Co	Art of producing very thin steel and like sheets in wide strips
NL269801A (nl)	1960-10-04	1964-03-10	Farbwerke Höchst Ag	Werkwijze ter bereiding van in water onoplosbare kleurstoffen
DE2233977A1 (de)	1971-07-14	1973-02-01	Unilever Nv	Verfahren zur herstellung oxydierter kohlenhydrate
GB1419080A (en)	1972-12-29	1975-12-24	Cheminova As	Chemical compounds having juvenile hormone activity
US4179337A (en)	1973-07-20	1979-12-18	Davis Frank F	Non-immunogenic polypeptides
US4125492A (en) *	1974-05-31	1978-11-14	Pedro Cuatrecasas	Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
US4061736A (en)	1975-02-02	1977-12-06	Alza Corporation	Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4001200A (en) *	1975-02-27	1977-01-04	Alza Corporation	Novel polymerized, cross-linked, stromal-free hemoglobin
US4001401A (en)	1975-02-02	1977-01-04	Alza Corporation	Blood substitute and blood plasma expander comprising polyhemoglobin
US4053590A (en) *	1975-02-27	1977-10-11	Alza Corporation	Compositions of matter comprising macromolecular hemoglobin
CA1055932A (fr)	1975-10-22	1979-06-05	Hematech Inc.	Succedane du sang comparable a l'hemoglobine
DE2616086C2 (de) *	1976-04-13	1986-04-03	Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg	Substanz zur Verwendung in einem kolloidalen Blutvolumenersatzmittel aus Hydroxyethylstärke und Hämoglobin
GB1578348A (en)	1976-08-17	1980-11-05	Pharmacia Ab	Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic
FR2378094A2 (fr)	1977-01-24	1978-08-18	Inst Nat Sante Rech Med	Nouveaux reactifs biologiques constitues par des supports solides sur lesquels sont couples des composes organiques comportant un residu glucidique
EP0019403B1 (fr) *	1979-05-10	1985-07-31	American Hospital Supply Corporation	Support de médicament en hydroxyalkylamidon
DE3029307A1 (de) *	1980-08-01	1982-03-04	Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg	Haemoglobin enthaltendes blutersatzmittel
US4454161A (en)	1981-02-07	1984-06-12	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Process for the production of branching enzyme, and a method for improving the qualities of food products therewith
JPS57206622A (en)	1981-06-10	1982-12-18	Ajinomoto Co Inc	Blood substitute
FI82266C (fi)	1982-10-19	1991-02-11	Cetus Corp	Foerfarande foer framstaellning av il-2 -mutein.
EP0127839B1 (fr)	1983-05-27	1992-07-15	THE TEXAS A&M UNIVERSITY SYSTEM	Procédé pour la préparation d'un vecteur recombinant d'expression de baculovirus
IN163192B (fr)	1983-10-11	1988-08-20	Fidia Spa
US4703008A (en)	1983-12-13	1987-10-27	Kiren-Amgen, Inc.	DNA sequences encoding erythropoietin
NZ210501A (en)	1983-12-13	1991-08-27	Kirin Amgen Inc	Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4496689A (en)	1983-12-27	1985-01-29	Miles Laboratories, Inc.	Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4952496A (en) *	1984-03-30	1990-08-28	Associated Universities, Inc.	Cloning and expression of the gene for bacteriophage T7 RNA polymerase
IL77081A (en)	1984-12-04	1999-10-28	Genetics Inst	Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
SK280623B6 (sk) *	1985-01-03	2000-05-16	Genetics Institute	Rekombinantný dna plazmidový vektor, cicavčia bunk
DE3501616A1 (de)	1985-01-17	1986-07-17	Schering AG, 1000 Berlin und 4709 Bergkamen	Verfahren zur herstellung von hydroxylamin-derivaten
US4667016A (en)	1985-06-20	1987-05-19	Kirin-Amgen, Inc.	Erythropoietin purification
US4766106A (en)	1985-06-26	1988-08-23	Cetus Corporation	Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4863964A (en)	1985-07-02	1989-09-05	Biomedical Frontiers, Inc.	Method for the stabilization of deferoxamine to chelate free ions in physiological fluid
US5217998A (en) *	1985-07-02	1993-06-08	Biomedical Frontiers, Inc.	Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
GB8610551D0 (en)	1986-04-30	1986-06-04	Hoffmann La Roche	Polypeptide & protein derivatives
IT1203814B (it)	1986-06-30	1989-02-23	Fidia Farmaceutici	Esteri dell'acido alginico
FR2600894B1 (fr) *	1986-07-02	1989-01-13	Centre Nat Rech Scient	Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
US5214132A (en)	1986-12-23	1993-05-25	Kyowa Hakko Kogyo Co., Ltd.	Polypeptide derivatives of human granulocyte colony stimulating factor
US5362853A (en) *	1986-12-23	1994-11-08	Kyowa Hakko Kogyo Co., Ltd.	Polypeptide derivatives of human granulocyte colony stimulating factor
JP2594123B2 (ja)	1987-09-12	1997-03-26	株式会社林原生物化学研究所	減感作剤
EP0307827A3 (fr)	1987-09-15	1989-12-27	Kuraray Co., Ltd.	Complexes moléculaires, procédé de préparation et utilisation en médecine
IL84252A (en)	1987-10-23	1994-02-27	Yissum Res Dev Co	Phospholipase inhibiting compositions
US4904584A (en)	1987-12-23	1990-02-27	Genetics Institute, Inc.	Site-specific homogeneous modification of polypeptides
US4847325A (en) *	1988-01-20	1989-07-11	Cetus Corporation	Conjugation of polymer to colony stimulating factor-1
DK110188D0 (da)	1988-03-02	1988-03-02	Claus Selch Larsen	High molecular weight prodrug derivatives of antiinflammatory drugs
FR2630329B1 (fr)	1988-04-20	1991-07-05	Merieux Inst	Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
IT1219942B (it)	1988-05-13	1990-05-24	Fidia Farmaceutici	Esteri polisaccaridici
US4900780A (en)	1988-05-25	1990-02-13	Masonic Medical Research Laboratory	Acellular resuscitative fluid
US4925677A (en)	1988-08-31	1990-05-15	Theratech, Inc.	Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5420105A (en)	1988-09-23	1995-05-30	Gustavson; Linda M.	Polymeric carriers for non-covalent drug conjugation
US5218092A (en)	1988-09-29	1993-06-08	Kyowa Hakko Kogyo Co., Ltd.	Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
DE3836600A1 (de)	1988-10-27	1990-05-03	Wolff Walsrode Ag	Kohlensaeureester von polysacchariden und verfahren zu ihrer herstellung
JP2989002B2 (ja)	1988-12-22	1999-12-13	キリン―アムジエン・インコーポレーテツド	化学修飾顆粒球コロニー刺激因子
US6261800B1 (en) *	1989-05-05	2001-07-17	Genentech, Inc.	Luteinizing hormone/choriogonadotropin (LH/CG) receptor
DE19975071I2 (de)	1989-06-16	2000-02-03	Fresenius Ag	Hydroxyethylstaerke als Plasmaexpander Verfahren zu ihrer Herstellung und Verwendung als kolloidales Plasmaersatzmittel
JP2896580B2 (ja)	1989-08-25	1999-05-31	チッソ株式会社	アミロース―リゾチームハイブリッドと活性化糖およびその製造法
JP2838800B2 (ja)	1989-09-02	1998-12-16	株式会社林原生物化学研究所	減感作剤
KR100263845B1 (ko)	1989-10-13	2000-08-16	스튜어트 엘.왓트	에리트로포이에틴 동형체와 그의 제조방법 및 그를 포함하는제약학적 조성물
JP2975632B2 (ja)	1990-03-30	1999-11-10	生化学工業株式会社	グリコサミノグリカン修飾プロテイン
US5169784A (en)	1990-09-17	1992-12-08	The Texas A & M University System	Baculovirus dual promoter expression vector
DK130991D0 (da) *	1991-07-04	1991-07-04	Immunodex K S	Polymere konjugater
US5281698A (en) *	1991-07-23	1994-01-25	Cetus Oncology Corporation	Preparation of an activated polymer ester for protein conjugation
DE4130807A1 (de) *	1991-09-17	1993-03-18	Wolff Walsrode Ag	Verfahren zur herstellung von polysaccharidcarbonaten
US6172208B1 (en)	1992-07-06	2001-01-09	Genzyme Corporation	Oligonucleotides modified with conjugate groups
WO1994005332A2 (fr) *	1992-09-01	1994-03-17	Berlex Laboratories, Inc.	Glycolation de macromolecules glycosylees
GB2270920B (en) *	1992-09-25	1997-04-02	Univ Keele	Alginate-bioactive agent conjugates
CA2110543A1 (fr)	1992-12-09	1994-06-10	David E. Wright	Reactifs formant des chainons peg-hydrazone et peg-oxyme et derives proteiniques ainsi obtenus
FI935485A7 (fi)	1992-12-09	1994-06-10	Ortho Pharma Corp	PEG-hydratsoni- ja PEG-oksiimisidoksen muodostavat reagenssit ja niiden proteiinijohdannaiset
NZ250375A (en)	1992-12-09	1995-07-26	Ortho Pharma Corp	Peg hydrazone and peg oxime linkage forming reagents and protein derivatives
EP0601417A3 (fr)	1992-12-11	1998-07-01	Hoechst Aktiengesellschaft	Physiologiquement compatible et dégradable bloques de récepteur d'hydrate de carbone à base de polymère, procédé de leur préparation et leur utilisation
US5581476A (en)	1993-01-28	1996-12-03	Amgen Inc.	Computer-based methods and articles of manufacture for preparing G-CSF analogs
AU668294B2 (en)	1993-03-16	1996-04-26	Hemosol Inc.	Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides
WO1994028024A1 (fr) *	1993-06-01	1994-12-08	Enzon, Inc.	Polymere modifie aux glucides presentant une activite erythropoïetique
IL110669A (en)	1993-08-17	2008-11-26	Kirin Amgen Inc	Erythropoietin analogs
US5840900A (en)	1993-10-20	1998-11-24	Enzon, Inc.	High molecular weight polymer-based prodrugs
JPH07188291A (ja)	1993-12-27	1995-07-25	Hayashibara Biochem Lab Inc	蛋白質とその製造方法並びに用途
US5876980A (en)	1995-04-11	1999-03-02	Cytel Corporation	Enzymatic synthesis of oligosaccharides
US6214331B1 (en)	1995-06-06	2001-04-10	C. R. Bard, Inc.	Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US5736533A (en)	1995-06-07	1998-04-07	Neose Technologies, Inc.	Bacterial inhibition with an oligosaccharide compound
WO1996040662A2 (fr) *	1995-06-07	1996-12-19	Cellpro, Incorporated	Composes de liaison contenant un groupe aminooxy et leur utilisation pour la formation de conjugues
US5981507A (en)	1995-12-14	1999-11-09	Advanced Magnetics, Inc.	Polymeric carriers linked to nucleotide analogues via a phosphoramide bond
US5723589A (en)	1995-12-21	1998-03-03	Icn Pharmaceuticals	Carbohydrate conjugated bio-active compounds
WO1997033552A1 (fr)	1996-03-12	1997-09-18	Pg-Txl Company, L.P.	Bioprecurseurs de paclitaxel solubles dans l'eau
US5696152A (en)	1996-05-07	1997-12-09	Wisconsin Alumni Research Foundation	Taxol composition for use as organ preservation and cardioplegic agents
TW517067B (en) *	1996-05-31	2003-01-11	Hoffmann La Roche	Interferon conjugates
DE19628705A1 (de) *	1996-07-08	1998-01-15	Fresenius Ag	Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe
US5770645A (en)	1996-08-02	1998-06-23	Duke University Medical Center	Polymers for delivering nitric oxide in vivo
US5851984A (en)	1996-08-16	1998-12-22	Genentech, Inc.	Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
US6011008A (en)	1997-01-08	2000-01-04	Yissum Research Developement Company Of The Hebrew University Of Jerusalem	Conjugates of biologically active substances
US5952347A (en)	1997-03-13	1999-09-14	Merck & Co., Inc.	Quinoline leukotriene antagonists
US6299881B1 (en) *	1997-03-24	2001-10-09	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
US5990237A (en)	1997-05-21	1999-11-23	Shearwater Polymers, Inc.	Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
DE69835308T2 (de)	1997-08-07	2007-08-09	University Of Utah Research Foundation, Salt Lake City	Prodrugs und Konjugate von Selenoenthaltenden Verbindungen und ihre Verwendung
US5847110A (en)	1997-08-15	1998-12-08	Biomedical Frontiers, Inc.	Method of reducing a schiff base
US6875594B2 (en)	1997-11-13	2005-04-05	The Rockefeller University	Methods of ligating expressed proteins
US6624142B2 (en)	1997-12-30	2003-09-23	Enzon, Inc.	Trimethyl lock based tetrapartate prodrugs
US6740634B1 (en) *	1998-01-16	2004-05-25	Takeda Chemical Industries, Ltd.	Sustained release compositions, process for producing the same and utilization thereof
DE19808079A1 (de)	1998-02-20	1999-08-26	Schering Ag	Hydroxyethylstärke-Konjugate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US6596135B1 (en)	1998-03-05	2003-07-22	Asahi Glass Company, Limited	Sputtering target, transparent conductive film, and method for producing the same
CA2233725A1 (fr) *	1998-03-31	1999-09-30	Hemosol Inc.	Complexes d'amidon hydroxyethyles d'hemoglobine
US6153655A (en)	1998-04-17	2000-11-28	Enzon, Inc.	Terminally-branched polymeric linkers and polymeric conjugates containing the same
US6660843B1 (en)	1998-10-23	2003-12-09	Amgen Inc.	Modified peptides as therapeutic agents
US6261594B1 (en)	1998-11-25	2001-07-17	The University Of Akron	Chitosan-based nitric oxide donor compositions
EP1035137A1 (fr) *	1999-03-12	2000-09-13	Pasteur Merieux Serums Et Vaccins	Procédé d'amination réductrice des polysaccharides
CZ299516B6 (cs)	1999-07-02	2008-08-20	F. Hoffmann-La Roche Ag	Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
US7279176B1 (en)	1999-09-02	2007-10-09	Rice University	Nitric oxide-producing hydrogel materials
US20020065410A1 (en)	1999-12-02	2002-05-30	Antrim Richard L.	Branched starches and branched starch hydrolyzates
US6555660B2 (en) *	2000-01-10	2003-04-29	Maxygen Holdings Ltd.	G-CSF conjugates
US6749865B2 (en)	2000-02-15	2004-06-15	Genzyme Corporation	Modification of biopolymers for improved drug delivery
US6586398B1 (en)	2000-04-07	2003-07-01	Amgen, Inc.	Chemically modified novel erythropoietin stimulating protein compositions and methods
JP2001294601A (ja)	2000-04-11	2001-10-23	Akita Prefecture	高度分岐澱粉と該高度分岐澱粉の製造方法
JP2002003398A (ja)	2000-04-17	2002-01-09	Ltt Institute Co Ltd	徐放製剤、その製造法及びワクチン
DE10023051B4 (de) *	2000-05-11	2004-02-19	Roche Diagnostics Gmbh	Verfahren zur Herstellung von Fluoresceinisothiocyanat-Sinistrin, dessen Verwendung und Fluoresceinisothiocyanat-Sinistrin enthaltende diagnostische Zubereitung
FR2811967B1 (fr)	2000-07-24	2002-12-13	Cebal	Tube muni d'une tete de fixation pour divers bouchages et les divers bouchages munis de moyens de fixation sur ledit tube
US6417347B1 (en)	2000-08-24	2002-07-09	Scimed Life Systems, Inc.	High yield S-nitrosylation process
DE10041541A1 (de)	2000-08-24	2002-03-14	Michael Duchene	Rekombinante Allergene aus der Motte Plodia interpunctella
AU2001273385B2 (en)	2000-09-08	2005-04-07	Gryphon Therapeutics, Inc.	Polymer-modified synthetic proteins
DE10105921A1 (de)	2001-02-09	2002-08-14	Braun Melsungen Ag	An Kolloide gebundene Arzneiwirkstoffe
DE10112825A1 (de)	2001-03-16	2002-10-02	Fresenius Kabi De Gmbh	HESylierung von Wirkstoffen in wässriger Lösung
DE10126158A1 (de)	2001-05-30	2002-12-12	Novira Chem Gmbh	Eine Methode zur Synthese von Gemischen einfach aktivierter und nicht aktivierter Polyoxyalkylene zur Modifizierung von Proteinen
DE10129369C1 (de) *	2001-06-21	2003-03-06	Fresenius Kabi De Gmbh	Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
DE10135694A1 (de)	2001-07-21	2003-02-06	Supramol Parenteral Colloids	Amphiphile Stärke-und Hydroxyethylstärke-Konjugate
US7125843B2 (en) *	2001-10-19	2006-10-24	Neose Technologies, Inc.	Glycoconjugates including more than one peptide
US7179617B2 (en)	2001-10-10	2007-02-20	Neose Technologies, Inc.	Factor IX: remolding and glycoconjugation of Factor IX
WO2003035665A1 (fr)	2001-10-26	2003-05-01	Noxxon Pharma Ag	Acide l-nucleique modifie
US6375846B1 (en)	2001-11-01	2002-04-23	Harry Wellington Jarrett	Cyanogen bromide-activation of hydroxyls on silica for high pressure affinity chromatography
DE10155098A1 (de)	2001-11-09	2003-05-22	Supramol Parenteral Colloids	Mittel zur Prävention von mykotischen Kontaminationen bei der Zell- und Gewebekultur bakteriellen, pflanzlichen, animalischen und humanen Ursprungs, bestehend aus Polyen-Makrolid-Konjugaten mit Polysacchariden
US6916962B2 (en)	2001-12-11	2005-07-12	Sun Bio, Inc.	Monofunctional polyethylene glycol aldehydes
DE10207072A1 (de) *	2002-02-20	2003-08-28	Supramol Parenteral Colloids	Stärkederivate, ihre Konjugate und Verfahren zur Herstellung derselben
DE10209821A1 (de)	2002-03-06	2003-09-25	Biotechnologie Ges Mittelhesse	Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) *	2002-03-06	2003-09-25	Biotechnologie Ges Mittelhesse	Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE60315145T2 (de)	2002-03-13	2008-04-30	Beijing Jiankai Technology Co., Ltd.	Hydrophiles polymerderivat mit y-verzweigung und herstellungsverfahren dafür; obige verbindung enthaltender medizinischer verbundwerkstoff
DE10217994A1 (de)	2002-04-23	2003-11-06	Supramol Parenteral Colloids	Konjugate von hyperverzweigten Polysacchariden
EP1514107B1 (fr)	2002-06-03	2013-05-15	The Institute for Systems Biology	Procedes d'analyse proteomique quantitative de glycoproteines
US20040101546A1 (en)	2002-11-26	2004-05-27	Gorman Anne Jessica	Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
AU2003270454B2 (en)	2002-09-09	2010-05-20	Nektar Therapeutics	Water-soluble polymer alkanals
EP1591467A1 (fr)	2002-09-09	2005-11-02	Nektar Therapeutics Al, Corporation	Conjugue d un polyethylene glycol comprenant un group terminal alcanal et un hormone de croissance humaine
DE02020425T1 (de)	2002-09-11	2004-07-15	Fresenius Kabi Deutschland Gmbh	Hasylierte Polypeptide, besonders hasyliertes Erythropoietin
RU2329274C2 (ru)	2002-09-11	2008-07-20	Фрезениус Каби Дойчланд Гмбх	Способ получения производных гидроксиалкилкрахмала
DE10242076A1 (de)	2002-09-11	2004-03-25	Fresenius Kabi Deutschland Gmbh	HAS-Allergen-Konjugate
US7538092B2 (en)	2002-10-08	2009-05-26	Fresenius Kabi Deutschland Gmbh	Pharmaceutically active oligosaccharide conjugates
DE10254745A1 (de)	2002-11-23	2004-06-03	Supramol Parenteral Colloids Gmbh	Imidazolide von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe
DE10256558A1 (de)	2002-12-04	2004-09-16	Supramol Parenteral Colloids Gmbh	Ester von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe
MXPA06001358A (es)	2003-08-08	2006-05-15	Fresenius Kabi Gmbh	Conjugados de hidroxialquil almidon y g-csf.
WO2005014655A2 (fr)	2003-08-08	2005-02-17	Fresenius Kabi Deutschland Gmbh	Conjugues d'amidon d'hydroxyalkyle et de proteine
EP1653991A2 (fr)	2003-08-08	2006-05-10	Fresenius Kabi Deutschland GmbH	Conjugues de polymere et de proteine lies au moyen d'un groupe de liaison oxime
BRPI0413450A (pt)	2003-08-08	2006-10-17	Fresenius Kabi De Gmbh	conjugados de hidroxialquil amido e g-csf
AU2005209303A1 (en)	2004-01-29	2005-08-11	Biosynexus, Inc.	Use of amino-oxy functional groups in the preparation of vaccines conjugates
DE102004009783A1 (de)	2004-02-28	2005-09-15	Supramol Parenteral Colloids Gmbh	Hyperverzweigte Stärkefraktion, Verfahren zu ihrer Herstellung und ihre Konjugate mit pharmazeutischen Wirkstoffen
TWI417303B (zh)	2004-03-11	2013-12-01	Fresenius Kabi De Gmbh	經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物
CN1929865B (zh)	2004-03-11	2011-11-16	费森尤斯卡比德国有限公司	羟烷基淀粉和蛋白质的接合物
EP1758608A2 (fr)	2004-03-11	2007-03-07	Fresenius Kabi Deutschland GmbH	Conjugues d'hydroxy-ethyl-amidon et d'erythropoietine
WO2005112954A1 (fr)	2004-05-14	2005-12-01	William Marsh Rice University	Compositions de déclenchement d’oxyde nitrique et méthodes associées
EP1861124A2 (fr)	2005-03-11	2007-12-05	Fresenius Kabi Deutschland GmbH	Production de glycoproteines bioactives a partir d'un materiau de depart inactif
EP1762250A1 (fr)	2005-09-12	2007-03-14	Fresenius Kabi Deutschland GmbH	Conjugués d' amidon hydroxyalkyle et une substance active obtenue par ligation chimique via thiazolidine
CA2628055C (fr)	2005-10-31	2013-10-01	Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services	Diazeniumdiolates lies par un carbone, liberant de l'oxyde nitrique et derives de polysaccharides
JP2009093397A (ja)	2007-10-09	2009-04-30	Panasonic Corp	タッチパネル及びこれを用いた入力装置
EP2070951A1 (fr)	2007-12-14	2009-06-17	Fresenius Kabi Deutschland GmbH	Procédé de production d'un dérivé hydroxyalkyle de l'amidon avec deux liens
EP2070950A1 (fr)	2007-12-14	2009-06-17	Fresenius Kabi Deutschland GmbH	Dérivés hydroxyalkylés de l'amidon et leur procédé de préparation
KR101705077B1 (ko)	2008-10-07	2017-02-09	렉산 파마슈티컬스, 인코포레이티드	Ｈｐｍａ-도세탁셀 또는 젬시타빈 컨쥬게이트 및 이의 용도

2003
- 2003-08-08 RU RU2005110415/04A patent/RU2329274C2/ru not_active IP Right Cessation
- 2003-08-08 AU AU2003260393A patent/AU2003260393B2/en not_active Ceased
- 2003-08-08 WO PCT/EP2003/008858 patent/WO2004024761A1/fr not_active Ceased
- 2003-08-08 BR BR0314227-2A patent/BR0314227A/pt not_active Application Discontinuation
- 2003-08-08 RU RU2005110423/04A patent/RU2328505C2/ru not_active IP Right Cessation
- 2003-08-08 JP JP2004535075A patent/JP2006516534A/ja not_active Withdrawn
- 2003-08-08 AU AU2003253399A patent/AU2003253399B2/en not_active Ceased
- 2003-08-08 CN CNA038214644A patent/CN1681844A/zh active Pending
- 2003-08-08 WO PCT/EP2003/008859 patent/WO2004024777A1/fr not_active Ceased
- 2003-08-08 AU AU2003255406A patent/AU2003255406B2/en not_active Ceased
- 2003-08-08 BR BR0314107-1A patent/BR0314107A/pt not_active Application Discontinuation
- 2003-08-08 WO PCT/EP2003/008829 patent/WO2004024776A1/fr not_active Ceased
- 2003-08-08 CA CA002495242A patent/CA2495242A1/fr not_active Abandoned
- 2003-08-08 CA CA2496317A patent/CA2496317C/fr not_active Expired - Fee Related
- 2003-08-08 KR KR1020057003928A patent/KR101174510B1/ko not_active Expired - Fee Related
- 2003-08-08 BR BR0314106-3A patent/BR0314106A/pt not_active IP Right Cessation
- 2003-08-08 MX MXPA05002594A patent/MXPA05002594A/es active IP Right Grant
- 2003-08-08 KR KR1020057004002A patent/KR101045401B1/ko not_active Expired - Fee Related
- 2003-08-08 PL PL374490A patent/PL217085B1/pl unknown
- 2003-08-08 KR KR1020057003902A patent/KR101045422B1/ko not_active Expired - Fee Related
- 2003-08-08 RU RU2005110412/04A patent/RU2326891C2/ru not_active IP Right Cessation
- 2003-08-08 IL IL16650603A patent/IL166506A0/xx unknown
- 2003-08-08 PL PL03375037A patent/PL375037A1/xx unknown
- 2003-08-08 MX MXPA05002591A patent/MXPA05002591A/es active IP Right Grant
- 2003-08-08 MX MXPA05002593A patent/MXPA05002593A/es active IP Right Grant
- 2003-08-08 CN CNB038214652A patent/CN100348618C/zh not_active Expired - Fee Related
- 2003-08-08 PL PL374969A patent/PL216545B1/pl not_active IP Right Cessation
- 2003-08-29 AR ARP030103141A patent/AR041097A1/es active IP Right Grant
- 2003-09-10 TW TW092124954A patent/TW200418875A/zh unknown
- 2003-09-11 PT PT03020424T patent/PT1398327E/pt unknown
- 2003-09-11 ES ES03020423T patent/ES2213505T3/es not_active Expired - Lifetime
- 2003-09-11 EP EP08012908A patent/EP2017287A3/fr not_active Withdrawn
- 2003-09-11 DE DE60330098T patent/DE60330098D1/de not_active Expired - Lifetime
- 2003-09-11 DK DK03020423T patent/DK1398322T3/da active
- 2003-09-11 EP EP09012453A patent/EP2143736B1/fr not_active Expired - Lifetime
- 2003-09-11 SI SI200331431T patent/SI1398327T1/sl unknown
- 2003-09-11 EP EP10011836.3A patent/EP2272865A3/fr not_active Withdrawn
- 2003-09-11 AT AT03020424T patent/ATE406387T1/de active
- 2003-09-11 DK DK03020425.9T patent/DK1398328T3/da active
- 2003-09-11 EP EP03020424A patent/EP1398327B1/fr not_active Expired - Lifetime
- 2003-09-11 DE DE0001398322T patent/DE03020423T1/de active Pending
- 2003-09-11 EP EP10011835A patent/EP2316850A3/fr not_active Withdrawn
- 2003-09-11 EP EP03020423A patent/EP1398322B1/fr not_active Expired - Lifetime
- 2003-09-11 DE DE0001398327T patent/DE03020424T1/de active Pending
- 2003-09-11 DE DE0001398328T patent/DE03020425T1/de active Pending
- 2003-09-11 ES ES03020424T patent/ES2213506T3/es not_active Expired - Lifetime
- 2003-09-11 DK DK03020424T patent/DK1398327T3/da active
- 2003-09-11 DE DE60323192T patent/DE60323192D1/de not_active Expired - Lifetime
- 2003-09-11 ES ES09012453T patent/ES2399006T3/es not_active Expired - Lifetime
- 2003-09-11 EP EP03020425A patent/EP1398328B1/fr not_active Expired - Lifetime
- 2003-09-11 PT PT03020423T patent/PT1398322E/pt unknown
- 2003-09-11 AT AT03020425T patent/ATE449112T1/de active
- 2003-09-11 PT PT03020425T patent/PT1398328E/pt unknown
- 2003-09-11 AT AT03020423T patent/ATE323723T1/de active
- 2003-09-11 EP EP09014352A patent/EP2154160A1/fr not_active Withdrawn
- 2003-09-11 DE DE60304640T patent/DE60304640T2/de not_active Expired - Lifetime
- 2003-09-11 SI SI200331733T patent/SI1398328T1/sl unknown
- 2003-09-11 ES ES03020425T patent/ES2213507T3/es not_active Expired - Lifetime
- 2003-09-11 DE DE20321836U patent/DE20321836U1/de not_active Expired - Lifetime
2004
- 2004-08-06 ZA ZA200600651A patent/ZA200600651B/xx unknown
- 2004-08-09 AR ARP040102851A patent/AR045235A1/es active IP Right Grant
- 2004-08-09 AR ARP040102850A patent/AR045234A1/es active IP Right Grant
2005
- 2005-01-26 IL IL166506A patent/IL166506A/en not_active IP Right Cessation
- 2005-02-16 IL IL166930A patent/IL166930A/en not_active IP Right Cessation
- 2005-02-16 IL IL166931A patent/IL166931A/en not_active IP Right Cessation
- 2005-03-11 US US11/078,582 patent/US8618266B2/en not_active Expired - Fee Related
- 2005-03-11 US US11/077,906 patent/US7815893B2/en not_active Expired - Fee Related
- 2005-03-11 US US11/078,098 patent/US20050238723A1/en not_active Abandoned
- 2005-03-17 NO NO20051419A patent/NO20051419L/no active IP Right Review Request
- 2005-03-17 NO NO20051427A patent/NO20051427L/no not_active Application Discontinuation
2009
- 2009-07-30 IL IL200150A patent/IL200150A0/en unknown
- 2009-11-20 AU AU2009238372A patent/AU2009238372B2/en not_active Ceased
2010
- 2010-02-16 CY CY20101100153T patent/CY1109813T1/el unknown
- 2010-06-04 MX MX2010006175A patent/MX2010006175A/es active IP Right Grant
- 2010-06-28 US US12/824,618 patent/US20120046240A9/en not_active Abandoned
- 2010-07-06 JP JP2010153807A patent/JP5455821B2/ja not_active Expired - Fee Related
- 2010-07-06 JP JP2010153808A patent/JP5275293B2/ja not_active Expired - Fee Related
- 2010-08-12 US US12/855,381 patent/US8475765B2/en not_active Expired - Fee Related
- 2010-11-30 JP JP2010266646A patent/JP2011089125A/ja active Pending
2011
- 2011-01-14 AU AU2011200158A patent/AU2011200158B2/en not_active Ceased
- 2011-01-14 AU AU2011200219A patent/AU2011200219B2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2011200158B2 (en)	2012-08-02
DE03020423T1 (de)	2004-07-15
EP2154160A1 (fr)	2010-02-17
US20050238723A1 (en)	2005-10-27
EP2017287A3 (fr)	2009-11-04
AU2003253399B2 (en)	2010-10-14
HK1063475A1 (en)	2004-12-31
KR20050061466A (ko)	2005-06-22
IL166930A (en)	2012-08-30
AR045235A1 (es)	2005-10-19
EP2272865A3 (fr)	2014-06-18
RU2005110412A (ru)	2006-01-20
AU2009238372B2 (en)	2012-08-23
DE60304640T2 (de)	2007-05-16
JP2010265464A (ja)	2010-11-25
RU2005110415A (ru)	2006-08-27
US20100317609A1 (en)	2010-12-16
ES2213507T1 (es)	2004-09-01
AU2011200158A1 (en)	2011-02-03
ES2213506T1 (es)	2004-09-01
RU2329274C2 (ru)	2008-07-20
MX2010006175A (es)	2010-07-05
CA2496317C (fr)	2014-02-18
ATE406387T1 (de)	2008-09-15
EP1398322B1 (fr)	2006-04-19
US20060019877A1 (en)	2006-01-26
US7815893B2 (en)	2010-10-19
PL217085B1 (pl)	2014-06-30
US20120046240A9 (en)	2012-02-23
WO2004024777A1 (fr)	2004-03-25
BR0314227A (pt)	2005-10-25
MXPA05002591A (es)	2005-09-20
PL375037A1 (en)	2005-11-14
RU2005110423A (ru)	2006-01-20
EP1398327B1 (fr)	2008-08-27
KR20050072417A (ko)	2005-07-11
PL374969A1 (en)	2005-11-14
WO2004024776A1 (fr)	2004-03-25
DE60330098D1 (de)	2009-12-31
SI1398327T1 (sl)	2009-02-28
DE03020424T1 (de)	2004-07-15
EP2017287A2 (fr)	2009-01-21
EP1398328A1 (fr)	2004-03-17
BR0314107A (pt)	2005-07-19
MXPA05002593A (es)	2005-05-27
IL166506A0 (en)	2006-01-15
EP1398328B1 (fr)	2009-11-18
DE03020425T1 (de)	2004-07-15
DE60304640D1 (de)	2006-05-24
IL166506A (en)	2010-02-17
CN1681846A (zh)	2005-10-12
EP2316850A2 (fr)	2011-05-04
AU2003255406A1 (en)	2004-04-30
AU2003255406B2 (en)	2009-09-10
KR20050075336A (ko)	2005-07-20
DK1398327T3 (da)	2008-11-10
MXPA05002594A (es)	2005-05-27
CN100348618C (zh)	2007-11-14
ZA200600651B (en)	2007-04-25
AU2011200219B2 (en)	2012-05-17
JP2010248528A (ja)	2010-11-04
US8618266B2 (en)	2013-12-31
EP2143736B1 (fr)	2012-11-07
DK1398328T3 (da)	2010-03-08
KR101045422B1 (ko)	2011-06-30
JP5455821B2 (ja)	2014-03-26
CA2496317A1 (fr)	2004-03-25
PT1398328E (pt)	2010-02-19
ATE323723T1 (de)	2006-05-15
JP2006516534A (ja)	2006-07-06
AU2009238372A1 (en)	2009-12-17
IL166931A (en)	2012-06-28
CN1681844A (zh)	2005-10-12
KR101045401B1 (ko)	2011-06-30
AR045234A1 (es)	2005-10-19
JP5275293B2 (ja)	2013-08-28
ES2213507T3 (es)	2010-04-15
CY1109813T1 (el)	2014-09-10
HK1063478A1 (en)	2004-12-31
ES2213505T3 (es)	2006-11-16
US8475765B2 (en)	2013-07-02
RU2328505C2 (ru)	2008-07-10
JP2011089125A (ja)	2011-05-06
AR041097A1 (es)	2005-05-04
AU2003260393B2 (en)	2009-10-01
ES2399006T3 (es)	2013-03-25
AU2003260393A1 (en)	2004-04-30
US20110054152A1 (en)	2011-03-03
SI1398328T1 (sl)	2010-02-26
US20050234230A1 (en)	2005-10-20
NO20051427L (no)	2005-05-31
EP2143736A1 (fr)	2010-01-13
DE60323192D1 (de)	2008-10-09
ES2213505T1 (es)	2004-09-01
EP1398322A1 (fr)	2004-03-17
EP2316850A3 (fr)	2011-11-09
WO2004024777A8 (fr)	2005-03-24
RU2326891C2 (ru)	2008-06-20
EP2272865A2 (fr)	2011-01-12
CA2495242A1 (fr)	2004-03-25
ATE449112T1 (de)	2009-12-15
PT1398327E (pt)	2008-10-31
WO2004024761A1 (fr)	2004-03-25
AU2011200219A1 (en)	2011-02-10
KR101174510B1 (ko)	2012-08-16
TW200418875A (en)	2004-10-01
PT1398322E (pt)	2006-08-31
HK1063477A1 (en)	2004-12-31
PL374490A1 (en)	2005-10-31
BR0314106A (pt)	2005-07-19
AU2003253399A1 (en)	2004-04-30
ES2213506T3 (es)	2009-02-16
IL200150A0 (en)	2011-07-31
DE20321836U1 (de)	2011-04-07
PL216545B1 (pl)	2014-04-30
EP1398327A1 (fr)	2004-03-17
HK1136226A1 (en)	2010-06-25
DK1398322T3 (da)	2006-08-21

Publication	Publication Date	Title
NO20051419L (no)	2005-05-30	Hasylerte polypeptider, spesielt hasylerte erytropoietin
DE60203125D1 (de)	2005-04-07	Löslicher t zell rezeptor
DE68916423D1 (de)	1994-07-28	Enzymatisch verstärkter, piezoelektrischer, spezifischer bindungstest.
NO20012701L (no)	2001-07-25	Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter
BR0115222A (pt)	2003-10-07	Suporte de dados sem contato
CR9637A (es)	2008-03-06	Proteinas de enlace il-6
NO20052995D0 (no)	2005-06-17	1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer.
DE68903439D1 (de)	1992-12-17	Staerkemischungen, verwendbar als aeusserliche papierleimungsmittel.
ES2159579T3 (es)	2001-10-16	Procedimiento para la fabricacion de diisocianatos.
DE59712873D1 (de)	2007-09-20	Halogenpyrimidinylaryl(thio)ether als pestizide
NO20052363L (no)	2005-08-08	Interferon-alfa polypeptider og konjugater
TR199800084A3 (tr)	1998-08-21	Bifenilsülfonil ikameli bes üyeli heterosiklenler, bunlarin üretimi.
CY1111486T1 (el)	2015-08-05	Μιμητικα αντισωματα (mimetibodies) δεσμευμενα με υποδοχεα μελανοκορτινης, συνθεσεις, μεθοδοι και χρησεις
DK1259505T3 (da)	2004-08-30	1,3-dihydro-2H-indol-2-on-derivater og deres anvendelse som ligander for arginin-vasopressin-receptorerne V1B eller V1B og V1A
IT1284301B1 (it)	1998-05-18	Antenna a singolo o a doppio riflettore, a fasci sagomati, a polarizzazione lineare.
FI885852A7 (fi)	1990-06-17	Anordning foer sluta en foerpackning runt en vara, som skall foerpackas.
NO996041D0 (no)	1999-12-08	Takåsskjoet bestående av to eller flere trebjelker som stoeter mot og overlapper hverandre langsgående , så vel som festeelement for skjoeting av to over lappende endeområder til trebjelker for bruk som en takåskopling
TR200003467T2 (tr)	2001-04-20	Neisseria meningitidis antijenik polipeptidler, mütekabil polinükleotidler ve koruyucu antikorlar
NO985462L (no)	1998-11-23	Karbohydrat-derivater og fastfase-syntese derav
TR200001682T2 (tr)	2001-02-21	Değiştirilmiş biyolojik tanınma gösteren değiştirilmiş polisakaridler
FI892888A0 (fi)	1989-06-13	Foerfarande foer framstaellning av 2-furaldehyd, cellulosa samt lignin av lignocellulosaaemnen.
IT1313624B1 (it)	2002-09-09	Procedimento per la sintesi del ritonavir
TR200000234T2 (tr)	2000-08-21	Samandan yapısal pano
ES2130904B1 (es)	2000-02-16	Puerta cortafuegos de doble hoja, perfeccionada.
ES1007954U (es)	1989-03-01	Dispositivo perforador de elementos laminares.

Legal Events

Date	Code	Title	Description
2015-02-23	PDP	Decision of opposition (par. 25 patent act)	Free format text: HEVNINGSKJENNELSE UTEN REALITETSUTTALELSE Effective date: 20131127

Date

Code

Title

Description

2015-02-23

PDP

Decision of opposition (par. 25 patent act)

Free format text: HEVNINGSKJENNELSE UTEN REALITETSUTTALELSE

Effective date: 20131127